(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology
 
 
Animal Health - 147
Biotechnology - 46
Drug Delivery - 18
Ethical Pharmaceuticals - 145
Healthcare - 47
Medical Equipment - 58
Pharmaceutical Intermediates - 22
 
 Pharmaceuticals & Biotechnology Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  3  4  5  6  7  8  9  10  11  12  Next »
Nanotechnology in Drug Delivery 2011-2021

The healthcare market is poised to see some of the earliest benefits of nanotechnology. Over the next decade, it will be one of nanotech’s highest growth sectors....

 

$4000.00
       
Epigenomics Present and Future Applications for Pharmaceuticals and Diagnostics

"Mabs" and molecular tests are among the growth industries of pharmaceuticals and diagnostics, but they may have competition long-term from an unexpected source. Epigenomics is a potential game-changer in the clinical therapeutics market and significant in testing as well....

 

$3995.00
       
Rapid Heart Rates Grow Faster as Drug Treatments Threaten Lives

Major safety fears over supraventricular tachycardia (SVT) medications are threatening many elderly patients, and even encouraging some to opt for surgery, claims a new report by healthcare experts GlobalData.

The new report, "Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019" shows that the prognosis for SVT is good if there are no associated co-morbidities, but with time, more frequent and long-lasting episodes are seen in almost all patients, who are forced to adhere to treatments potentially even more dangerous to their health than the condition itself....


 

$3995.00
       
Epigenetics: Applications for Pharmaceuticals and Diagnostics (Methylation, Histone Modification and miRNA expression)

Epigenetics (“Epi”; “over “ or “above” genetics) is recognized as those systems that control the expression of DNA-coded genes, but do not reside in the base pair sequences of the DNA. Rather, these control mechanisms are based on factors or molecules that bind to specific regions of the DNA (the genome), affecting gene expression....

 

$3995.00
       
Early Toxicology: Markets and Approaches

Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET....

 

$3995.00
       
What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)

Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines?...

 

$3995.00
       
The U.S. Market for Rx to OTC Switches, 6th Edition

The U.S....

 

$3995.00
       
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc....


 

$3995.00
       
The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods)

This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition:
  • Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort)
  • Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)
  • Parenteral Nutrition
For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates, over 65 population, and overall global population....

 

$3995.00
       
EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2022

Type 2 diabetes, formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose homeostasis and results from the body’s inability to make use of the available insulin along with relative insulin deficiency (WHO, 2013). This causes excess glucose production by liver cells along with impaired insulin secretion, which leads to an increased blood and urine glucose level....

 

$3995.00
       
EpiCast Report: Asthma - Epidemiology Forecast to 2022

Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004)....

 

$3995.00
       
The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

This Kalorama Information report The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment.

 

$3995.00
       
PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs

Summary

The Innovative Mid-Cap Biotech Benchmark Report applies GlobalData’s proprietary ranking methodology to compare the competitive position of 15 innovative biotech companies on 20 financial metrics. The performances of these companies are analyzed on financial performance, cost-containment, capital structure and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders....

 

$3995.00
       
The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living

The advancing age of the population makes long-term care an important consideration for health marketers. This report, The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living covers the most important segments of the long term care industry, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis:
  • Nursing care;
  • Home care;
  • Hospice care;
  • Assisted living....

 

$3995.00
       
The Market for Home Care Products

This report, The Market for Home Care Products, 7th. Edition covers the market for products specially designed to assist with regular tasks of daily living....

 

$3995.00
       
Laboratory Information Systems (LIS/LIMS) Markets

Automating instruments in the laboratory has created a demand for similar automation of information management systems, a need for speeding the turnaround of data and increased access to information resources. For this reason, the market for computer systems in the lab is a need-to-know area both for IT companies and diagnostic companies....

 

$3995.00
       
Diabetic Foot Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, “Diabetic Foot Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Diabetic Foot Ulcer Therapeutics market....

 

$3995.00
       
Overweight and Obesity - Epidemiology Forecast to 2022

Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood of developing type 2 diabetes and cardiovascular diseases. Obesity is an escalating public health problem with an increasing worldwide prevalence and has become a well-known threat to public health....

 

$3995.00
       
« Previous     3  4  5  6  7  8  9  10  11  12   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X